Research
Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study
Nature ·
The Brief
- A pilot study examined pharmacist-led case-finding for short-acting beta-agonist (SABA) overuse in asthma.
- The approach was combined with fractional exhaled nitric oxide (FeNO) testing to support management of high-risk symptomatic patients.
- The study was listed in the nature.com subject feed dated 2026-11-20; the available source provides no summary of results.
Why it matters
It describes a possible way to identify asthma patients who overuse reliever inhalers and to support their management, but as a pilot study its effectiveness is not established.
Who’s affected
- clinicians and pharmacists involved in asthma care
- people with asthma who rely on reliever inhalers
- #asthma
- #pharmacy
- #saba
- #feno
- #respiratory medicine